Unilever plc (UL): price, analyst ratings, earnings and fundamentals

Updated 16 September 2026, 08:02 ET

Unilever plc (UL) closed at $62.44 on 15 September 2026, down 1.8%. The stock is up 0.6% over one month and down 0.7% over one year. It trades 16.7% below its 52-week high of $74.97. The company last reported on 28 July 2026 for H1 2026: EPS of $1.88, on revenue of $29.9 billion.

Price and performance

Last close$62.44
Day change-1.78%
1 week-1.73%
1 month+0.56%
3 months+6.39%
6 months-4.57%
Year to date-4.53%
1 year-0.72%
52-week high$74.97
52-week low$54.75
Volume2,864,921
Average volume, 3 months4,086,969
Market cap$136.9B

Performance figures use dividend and split adjusted closes over trading sessions, so a one-year move compares the last close with the close 252 sessions earlier. The 52-week range uses the adjusted daily highs and lows of the same window. Read the guide: Momentum, trend and technical indicators.

The live chart with technical indicators is in the app: open UL in FundSpec.

Analyst ratings

No analyst action on UL was recorded in the last 90 days; the most recent is from 21 August 2025.

Actions, 90 days0
Firms0
DateFirmActionPrice target
21 Aug 2025CICCInitiates Coverage On Outperform
19 Nov 2024Erste GroupDowngrades to Hold from Buy
22 Aug 2024B of A SecuritiesUpgrades to Buy from Underperform$47.00 to $72.00
23 May 2024JP MorganUpgrades to Overweight from Underweight
8 May 2024Argus ResearchMaintains Buy$58.00 to $60.00
27 Feb 2024Morgan StanleyDowngrades to Underweight from Equal-Weight$52.00 to $48.00
14 Mar 2022BernsteinUpgrades to Market Perform from Underperform
1 Nov 2021BernsteinUpgrades to Market Perform from Underperform
16 Sep 2021Deutsche BankDowngrades to Hold from Buy
8 Apr 2021Societe GeneraleDowngrades to Sell from Buy

A price target is one firm's twelve-month view, and the median across firms is a steadier reading than any single call. Upgrades and downgrades matter more when they change a rating, not only a target. Read the guide: What analyst ratings and price targets actually tell you.

Every action with the firm's history is in Analyst Ratings.

Earnings

The next report is scheduled for 11 March 2027 during the session for FY 2026, with EPS expected at $3.51 on revenue of $59.6 billion.

PeriodReportedEPS estimateEPS actualSurpriseRevenue
H1 202628 Jul 2026$1.88$29.9B
FY 202512 Mar 2026$3.59$58.8B
H1 202531 Jul 2025$1.74$32.9B
FY 202413 Mar 2025$3.23$65.9B
H1 202425 Jul 2024$1.74$33.5B
FY 20238 Feb 2024$2.80$64.2B
H1 202325 Jul 2023$1.50$32.9B
FY 20229 Feb 2023$2.70$63.1B

An earnings surprise is the reported EPS against the consensus estimate on the day. The price reaction depends as much on guidance and on what was already priced in as on the surprise itself. Read the guide: Earnings season: estimates, surprises and price reaction.

Estimates, confirmed dates and alerts for every company are in Earnings.

Fundamentals

On a trailing twelve month basis the company shows revenue growth of -3.77%, a gross margin of 46.95%, an operating margin of 17.89% and a return on equity of 56.37%.

Assets

LineAmount
Cash & Cash Equivalents$3,941,000,000
Accounts & Notes Receivable, Net$7,346,000,000
Inventory$4,043,000,000
Total Current Assets$17,066,000,000
Plant, Property & Equipment, Net$7,826,000,000
Goodwill Intangible Assets, Net$34,764,000,000
Deferred Tax Asset$1,146,000,000
Total Assets$70,471,000,000

Liabilities and equity

LineAmount
Total Current Liabilities$21,662,000,000
Long-term Debt$26,038,000,000
Minority Interest$2,057,000,000
Other Liabilities$137,000,000
Total Liabilities$52,884,000,000
Total Stockholders Equity$15,530,000,000
Total Liability & Stockholders Equity$70,471,000,000

Figures as filed with the SEC for the period ended 31 December 2025, in US dollars.

FundSpec fundamental metrics

Each metric is computed from the company's filings and ranked against every company FundSpec covers; the percentile is the share of covered companies with a lower value.

Liquidity

MetricValuePercentileWhat it measures
Cash Ratio0.1843rdCalculated as the ratio of Cash and cash equivalents / Current liabilities. This metric calculates the company's ability to repay its short-term debt
Current Ratio0.7938thCalculated as the ratio of Current Assets / Current Liabilities. The higher the current ratio, the more capable the company is of paying its obligations
Quick Ratio0.5234thCalculated as the ratio of (Cash + Marketable Securities + Accounts Receivable) / Current Liabilities. The quick ratio is a measure of how well a company can meet its short-term financial liabilities.

Leverage

MetricValuePercentileWhat it measures
Debt/Assets0.3778thCalculated as the ratio of Short-Term Debt + Long-Term Debt / Total Assets. The higher the ratio, the higher the degree of leverage, and consequently, financial risk
Debt/Equity1.6886thCalculated as the ratio of Total Liabilities / Shareholders' Equity. The ratio indicates how much debt a company is using to finance its assets relative to the amount of value represented in shareholders’ equity
Degree of Combined Leverage-0.7129thThis ratio summarizes the combined effect that the degree of operating leverage (DOL) and the degree of financial leverage have on earnings per share (EPS), given a particular change in sales
Degree of Financial Leverage1.1369thCalculated as the ratio of Percentage change in EPS / Percentage change in EBIT. A higher degree of financial leverage means that the company has more volatile EPS.
Degree of Operational Leverage-0.6330thCalculated as the ratio of Percentage change in EBIT / Percentage change in revenue. It is a measure of how earnings for the company is impacted by its sales activity.
Long Term Debt/Long Term Capital0.6374thCalculated as Long-Term Debt / (Long-Term Debt + Shareholders' Equity). The ratio is an indicator of the company's leverage

Earnings Growth (EBIT)

MetricValuePercentileWhat it measures
EBIT Pct Growth2.4%85thThe EBIT growth rate over the trailing twelve months (TTM)
EBIT Pct Growth 3 year CAGR-5.6%48thThe EBIT compound annual growth rate (CAGR) over the past 3 years
EBIT Pct Growth 5 year CAGR1.7%64thThe Adjusted EBIT compound annual growth rate (CAGR) over the past 5 years

Earnings Growth (EBITDA)

MetricValuePercentileWhat it measures
EBITDA Pct Growth2.8%87thThe EBITDA growth rate over the trailing twelve months (TTM)
EBITDA Pct Growth 3 year CAGR-17.1%38thThe EBITDA compound annual growth rate (CAGR) over the past 3 years
EBITDA Pct Growth 5 year CAGR0.3%19thThe EBITDA compound annual growth rate (CAGR) over the past 5 years

Profitability

MetricValuePercentileWhat it measures
Free Cashflow Margin Pct13.7%73rdCalculated as the ratio of Free Cashflow from Operating Activities / Net Sales. It measures how much per dollar of revenue the company is able to convert into free cash flow.
Gross Margin Pct46.9%60thCalculated as the ratio of Revenue - Cost of Goods Sold (COGS) / Revenue. The gross margin represents the percent of total sales revenue that the company retains after incurring the direct costs associated with producing the goods and services sold by a company.
Operating Margin Pct17.9%78thCalculated as the ratio of (Revenue - (Cost of Goods Sold + Labour + Sales, General & Administrative)) / Revenue. Operating margins are important because they measure efficiency. The higher the operating margin, the more profitable a company's core business is.
Operating Profit Pct Growth2.4%46thThe Operating Profit growth rate over the trailing twelve months (TTM)
Operating Profit Pct Growth 3 year CAGR (FY)-5.6%37thThe Operating Profit compound annual growth rate (CAGR) over the past 3 years
Operating Profit Pct Growth 5 year CAGR (FY)1.7%49thThe Operating Profit compound annual growth rate (CAGR) over the past 5 years
PreTax Margin Pct24.7%83rdCalculated as the ratio of (Gross profit - (Operating Expense + Interest Expense)) / Revenue. The pretax profit margin enables profitability to be compared across companies with significant differences in size, scale, capital structure and tax rates.
Return on Assets Pct13.3%93rdCalculated as the ratio of Net Income / Total Assets. It is an indicator of how efficient the company is at using its assets to generate earnings.
Return on Equity Pct56.4%96thCalculated as the ratio of Net Income / Shareholders' equity. It is a measure of how much profit a company generates with the money shareholders have invested.
Return on Invested Capital Pct14.7%83rdCalculated as the ratio of (Net Income - Dividends) / (Debt + Equity). It is a measure of how efficient the company is at allocating the capital under its control to profitable investments.

Cashflow

MetricValuePercentileWhat it measures
FCF Pct Growth-14.8%32ndThe Free Cash Flow growth rate over the trailing twelve months (TTM)
FCF Pct Growth 3 year CAGR19.0%51stThe Free Cash Flow compound annual growth rate (CAGR) over the past 3 years
FCF Pct Growth 5 year CAGR-15.4%31stThe Free Cash Flow compound annual growth rate (CAGR) over the past 5 years
FCF Return on Assets Pct9.2%83rdCalculated as the ratio of Cashflow from Operations / Total Assets. A high cash return on assets means a company is generating more cash flow from every asset dollar
Operating Cashflow Pct Growth-12.3%33rdThe Operating Cashflow growth rate over the trailing twelve months (TTM)
Operating Cashflow Pct Growth 3 year CAGR (FY)4.7%51stThe Operating Cashflow compound annual growth rate (CAGR) over the past 3 years
Operating Cashflow Pct Growth 5 year CAGR (FY)-1.6%40thThe Operating Cashflow compound annual growth rate (CAGR) over the past 5 years

Earnings Growth (Net Income)

MetricValuePercentileWhat it measures
Net Income Pct Growth57.2%73rdThe Net Income growth rate over the trailing twelve months (TTM)
Net Income Pct Growth 3 year CAGR6.6%56thThe Net Income compound annual growth rate (CAGR) over the past 3 years
Net Income Pct Growth 5 year CAGR10.5%66thThe Net Income compound annual growth rate (CAGR) over the past 5 years

Top Line Growth

MetricValuePercentileWhat it measures
Revenue Pct Growth-3.8%26thThe Revenue (Sales) growth rate over the trailing twelve months (TTM)
Revenue Pct Growth 3 year CAGR-5.6%22ndThe Revenue (Sales) compound annual growth rate (CAGR) over the past 3 years
Revenue Pct Growth 5 year CAGR-0.1%24thThe Revenue (Sales) compound annual growth rate (CAGR) over the past 5 years

Taxes

MetricValuePercentileWhat it measures
Effective Tax Rate Pct28.5%88thThe effective tax rate of the company over the trailing twelve months (TTM).

Margins and returns say how much of each dollar of sales becomes profit and how hard the balance sheet is working; leverage and liquidity say how much room the company has when conditions turn. Read the guide: A practical guide to discounted cash flow valuation.

Fair value, peer multiples and the full statement history are in the app: open UL in FundSpec.

SEC filings

The latest filing is a 20-F from 12 March 2026.

FiledFormDocument
12 Mar 202620-FView on sec.gov
13 Mar 202520-FView on sec.gov
14 Mar 202420-FView on sec.gov
13 Mar 202320-FView on sec.gov
9 Mar 202220-FView on sec.gov
10 Mar 202120-FView on sec.gov
9 Mar 202020-FView on sec.gov
11 Mar 201920-FView on sec.gov
8 Mar 201820-F/AView on sec.gov
28 Feb 201820-FView on sec.gov

Company profile

Exchange
NYSE
Sector
Pharmaceuticals, Biotech and Chemicals
Industry
Consumer Goods
Headquarters
Liverpool
Chief executive
Alan Jope
Employees
148,000
Website
unilever.com
SEC CIK
0000217410

Unilever PLC operates as a fast-moving consumer goods company. It operates through Beauty & Personal Care, Foods & Refreshment, and Home Care segments. The company offers its products under the Domestos, OMO, Seventh Generation, Ben & Jerry's, Knorr, Magnum, Wall's, Bango, the Vegetarian Butcher, Axe, Cif, Comfort, Dove, Lifebuoy, Lux, Rexona, Sunsilk, and Onnit brands.

Sector and peers

Unilever plc is part of the Pharmaceuticals, Biotech and Chemicals sector, which FundSpec tracks across 614 companies.

Companies in the same industry by market capitalization:

PG PROCTER & GAMBLE CoNVO Novo Nordisk A SSNY SanofiGSK GSK plcECL Ecolab Inc.ARGX Argenx SeTAK Takeda Pharmaceutical Co. Ltd.HLN Haleon plc

Put two of them side by side in Compare.

In FundSpec: the fair value estimate, the momentum reading, relative valuation against sector and industry peers, unusual options activity and AI model signals for UL are available to subscribers, with the same screen in the iOS and Android apps.

Open UL in FundSpec